Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-016324
Filing Date
2017-03-02
Accepted
2017-03-02 11:50:31
Documents
1
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6570
  Complete submission text file 0001209191-17-016324.txt   7965
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APOLLO ENDOSURGERY, INC., 1120 S. CAPITAL OF TEXAS HWY, BLDG. 1, SUITE 300 AUSTIN TX 78746
Business Address
McClellan William D. Jr. (Reporting) CIK: 0001689402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 17657567